How AI is transforming drug discovery, development and innovation

For the first time in human history, our ability to collect data on our biology has outpaced our ability to interpret and act on it

Outsourced drug discovery market to top $68bn in 2028

The global drug discovery market is expected to reach $68bn in 2028, according to a Visiongain report, with revenue gains driven by flexibility, agility, and the ability to innovate, says Evotec executive.

Many cancer drugs aim at the wrong molecular targets

Many experimental cancer drugs might be succeeding in unintended ways, finds a study that used CRISPR–Cas9 gene editing to investigate how such drugs interact with malignant cells.

An analysis of ten drugs found that the proteins they target are not crucial for the survival of cancer cells